Inactive Instrument
Isracann Biosciences Inc. Stock Canadian Securities Exchange
Stocks
IPOT
CA46501D1087
Pharmaceuticals
OTC Markets Traded| Market Cap | 6.06M 5.22M 4.91M 4.48M 8.39M 572M 8.41M 58.01M 22.51M 294M 22.77M 22.27M 946M | P/E 2021 |
-1.24x | P/E 2022 | -2.25x |
|---|---|---|---|---|---|
| Enterprise Value | 5.85M 5.03M 4.74M 4.33M 8.09M 552M 8.11M 55.96M 21.72M 283M 21.97M 21.49M 913M | EV / Sales 2021 |
-
| EV / Sales 2022 | - |
| Free-Float |
99.83% | Yield 2021 * |
-
| Yield 2022 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Ajay Kala
CEO | Chief Executive Officer | - | 20/01/2023 |
Yana Popova
DFI | Director of Finance/CFO | 44 | 15/11/2017 |
Bob Mehr
PRN | Corporate Officer/Principal | - | 15/04/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Sean Bromley
BRD | Director/Board Member | 36 | 19/12/2019 |
Yana Popova
BRD | Director/Board Member | 44 | 15/11/2017 |
George Vrabec
BRD | Director/Board Member | - | 15/04/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 176 | ||
| +0.49% | +2.04% | -13.05% | -7.12% | 13.56B | ||
| +1.17% | -1.39% | -31.19% | -56.60% | 4.93B | ||
| +2.06% | -1.16% | -0.84% | -2.86% | 4.62B | ||
| +0.95% | -1.92% | -1.24% | -31.51% | 3.95B | ||
| -0.06% | -1.29% | -18.62% | +1.44% | 3.57B | ||
| +0.82% | +2.75% | +1.02% | -1.57% | 3.53B | ||
| +0.34% | -1.07% | -9.74% | +4.62% | 3.28B | ||
| 0.00% | -2.11% | -21.76% | -16.34% | 2.33B | ||
| -0.20% | -2.69% | -25.61% | -17.29% | 1.68B | ||
| Average | +0.56% | +0.21% | -13.45% | -14.14% | 4.61B | |
| Weighted average by Cap. | +0.70% | +0.61% | -12.74% | -13.65% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | - | - |
| Net income | -25.16M -21.65M -20.37M -18.6M -34.8M -2.38B -34.9M -241M -93.39M -1.22B -94.46M -92.4M -3.93B | -4.69M -4.04M -3.8M -3.47M -6.49M -443M -6.51M -44.9M -17.42M -227M -17.62M -17.24M -732M |
| Net Debt | -1.96M -1.69M -1.59M -1.45M -2.71M -185M -2.72M -18.74M -7.27M -94.87M -7.35M -7.19M -306M | -214K -184K -173K -158K -296K -20.2M -297K -2.05M -794K -10.36M -803K -786K -33.39M |
Employees
-
Sector
Pharmaceuticals
















